Sri Krishna Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ACETAMINOPHEN USP, with a corresponding US DMF Number 15846.
Remarkably, this DMF maintains an Active status since its submission on February 06, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2013, and payment made on May 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II